Cardiac amyloidosis history and symptoms: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
The most common symptoms observed in patients with amyloidosis include | Amyloidosis is a multi-system disease involving many organs simultaneously. Approximately more than 50% of the patients with amyloidosis present with right heart failure symptoms. The most common symptoms observed in patients with cardiac amyloidosis include [[fatigue]], [[weight loss]], and [[purpura|periorbital purpura]].<ref name="pmid7878478">{{cite journal |author=Kyle RA, Gertz MA |title=Primary systemic amyloidosis: clinical and laboratory features in 474 cases |journal=[[Seminars in Hematology]] |volume=32 |issue=1 |pages=45–59 |year=1995 |month=January |pmid=7878478 |doi= |url= |accessdate=2012-02-13}}</ref> | ||
==Symptoms== | ==Symptoms== | ||
Revision as of 17:43, 3 May 2013
|
Cardiac amyloidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cardiac amyloidosis history and symptoms On the Web |
|
American Roentgen Ray Society Images of Cardiac amyloidosis history and symptoms |
|
Risk calculators and risk factors for Cardiac amyloidosis history and symptoms |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor: Cafer Zorkun, M.D., Ph.D. [2]; Lakshmi Gopalakrishnan, M.B.B.S. [3]
Overview
Amyloidosis is a multi-system disease involving many organs simultaneously. Approximately more than 50% of the patients with amyloidosis present with right heart failure symptoms. The most common symptoms observed in patients with cardiac amyloidosis include fatigue, weight loss, and periorbital purpura.[1]
Symptoms
- Cardiac amyloid deposition can cause symptoms suggestive of:
- congestive heart failure such as fatigue, dyspnea, orthopnea[1], peripheral edema, ascites and/or
- arrhythmias such as palpitations
- Postural hypotension may be observed in patients with subendothelial amyloid deposition.[2]
References
- ↑ 1.0 1.1 Kyle RA, Gertz MA (1995). "Primary systemic amyloidosis: clinical and laboratory features in 474 cases". Seminars in Hematology. 32 (1): 45–59. PMID 7878478. Unknown parameter
|month=ignored (help);|access-date=requires|url=(help) - ↑ Rapezzi C, Perugini E, Salvi F, Grigioni F, Riva L, Cooke RM, Ferlini A, Rimessi P, Bacchi-Reggiani L, Ciliberti P, Pastorelli F, Leone O, Bartolomei I, Pinna AD, Arpesella G, Branzi A (2006). "Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: towards tailoring of therapeutic strategies?". Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 13 (3): 143–53. doi:10.1080/13506120600877136. PMID 17062380. Retrieved 2012-02-13. Unknown parameter
|month=ignored (help)